Concentrix
CNXC
304 hedge funds and large institutions have $1.86B invested in Concentrix in 2026 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 128 increasing their positions, 81 reducing their positions, and 83 closing their positions.
58% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 81
14.48% more ownership
Funds ownership: 96.5% → 110.98% (+14%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
10% less funds holding
Funds holding: 336 → 304 (-32)
25% less capital invested
Capital invested by funds: $2.5B → $1.86B (-$633M)
33% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 83
85% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $66.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$68.1M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$66.8M |
| 3 |
KGI
Kopernik Global Investors
Tampa,
Florida
|
+$57.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$50.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$39.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$36.4M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$22.9M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$17M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$12.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$11.9M |
CNXC Hedge Fund Activity: Q1 2026 in Review
304 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Concentrix (CNXC) for Q1 2026, worth a combined $1.86B — down 25% from $2.5B a quarter earlier.
Sellers outnumbered buyers: 83 funds closed out of CNXC and 56 opened new positions — a net loss of 27 holders — while 81 trimmed existing stakes and 128 added.
The largest buyer was UBS Group, adding an estimated $68.1M. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $36.4M sold.
- 304 institutional investors held Concentrix (CNXC) as of Q1 2026, down from 336 in Q4 2025.
- Funds reported $1.86B of Concentrix stock for Q1 2026, down 25% quarter-over-quarter.
- 56 funds opened new Concentrix positions in Q1 2026 and 83 closed out, a net change of -27 holders.
- The largest Concentrix buyer in Q1 2026 was UBS Group, an estimated $68.1M added.
- The largest Concentrix seller in Q1 2026 was Invenomic Capital Management, an estimated $36.4M sold.
Based on aggregated 13F filings for Q1 2026.